Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Gastro Esophageal Reflux Disease (GERD) Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 H2 Receptor Antagonist
      • 1.3.3 Proton Pump Inhibitor (PPi)
      • 1.3.4 Antacids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Medical Center
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size
      • 2.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2014-2025
      • 2.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2014-2025
    • 2.2 Gastro Esophageal Reflux Disease (GERD) Drug Growth Rate by Regions
      • 2.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Regions 2014-2019
      • 2.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers
      • 3.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturers
    • 3.4 Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market
    • 3.6 Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 H2 Receptor Antagonist Sales and Revenue (2014-2019)
      • 4.1.2 Proton Pump Inhibitor (PPi) Sales and Revenue (2014-2019)
      • 4.1.3 Antacids Sales and Revenue (2014-2019)
    • 4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type
    • 4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type
    • 4.4 Gastro Esophageal Reflux Disease (GERD) Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

    6 United States

    • 6.1 United States Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Company
    • 6.2 United States Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Type
    • 6.3 United States Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Company
    • 7.2 European Union Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Type
    • 7.3 European Union Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Application

    8 China

    • 8.1 China Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Company
    • 8.2 China Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Type
    • 8.3 China Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Company
    • 9.2 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Type
    • 9.3 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Application
    • 9.4 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
      • 9.4.2 Rest of World Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Gastro Esophageal Reflux Disease (GERD) Drug
      • 10.1.4 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Novartis AG
      • 10.2.1 Novartis AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Gastro Esophageal Reflux Disease (GERD) Drug
      • 10.2.4 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
      • 10.2.5 Novartis AG Recent Development
    • 10.3 GlaxoSmithKline
      • 10.3.1 GlaxoSmithKline Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Gastro Esophageal Reflux Disease (GERD) Drug
      • 10.3.4 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
      • 10.3.5 GlaxoSmithKline Recent Development
    • 10.4 Merck
      • 10.4.1 Merck Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Gastro Esophageal Reflux Disease (GERD) Drug
      • 10.4.4 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
      • 10.4.5 Merck Recent Development
    • 10.5 Medtronic
      • 10.5.1 Medtronic Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Gastro Esophageal Reflux Disease (GERD) Drug
      • 10.5.4 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
      • 10.5.5 Medtronic Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels
      • 11.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
    • 11.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers

    12 Market Forecast

    • 12.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type
    • 12.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application
    • 12.4 Gastro Esophageal Reflux Disease (GERD) Drug Forecast by Regions
      • 12.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Gastro Esophageal Reflux Disease (GERD) Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gastro Esophageal Reflux Disease (GERD) Drug.

      This report studies the global market size of Gastro Esophageal Reflux Disease (GERD) Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Gastro Esophageal Reflux Disease (GERD) Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Novartis AG
      GlaxoSmithKline
      Merck
      Medtronic
      ...

      Market Segment by Product Type
      H2 Receptor Antagonist
      Proton Pump Inhibitor (PPi)
      Antacids

      Market Segment by Application
      Hospital
      Clinic
      Medical Center
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Gastro Esophageal Reflux Disease (GERD) Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Gastro Esophageal Reflux Disease (GERD) Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Gastro Esophageal Reflux Disease (GERD) Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now